rs1071676

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000576.3(IL1B):​c.*505G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.196 in 155,964 control chromosomes in the GnomAD database, including 3,233 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.20 ( 3151 hom., cov: 32)
Exomes 𝑓: 0.18 ( 82 hom. )

Consequence

IL1B
NM_000576.3 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.493

Publications

40 publications found
Variant links:
Genes affected
IL1B (HGNC:5992): (interleukin 1 beta) The protein encoded by this gene is a member of the interleukin 1 cytokine family. This cytokine is produced by activated macrophages as a proprotein, which is proteolytically processed to its active form by caspase 1 (CASP1/ICE). This cytokine is an important mediator of the inflammatory response, and is involved in a variety of cellular activities, including cell proliferation, differentiation, and apoptosis. The induction of cyclooxygenase-2 (PTGS2/COX2) by this cytokine in the central nervous system (CNS) is found to contribute to inflammatory pain hypersensitivity. Similarly, IL-1B has been implicated in human osteoarthritis pathogenesis. Patients with severe Coronavirus Disease 2019 (COVID-19) present elevated levels of pro-inflammatory cytokines such as IL-1B in bronchial alveolar lavage fluid samples. The lung damage induced by the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is to a large extent, a result of the inflammatory response promoted by cytokines such as IL-1B. This gene and eight other interleukin 1 family genes form a cytokine gene cluster on chromosome 2. [provided by RefSeq, Jul 2020]
IL1B Gene-Disease associations (from GenCC):
  • hereditary diffuse gastric adenocarcinoma
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.232 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL1BNM_000576.3 linkc.*505G>C 3_prime_UTR_variant Exon 7 of 7 ENST00000263341.7 NP_000567.1 P01584
IL1BXM_047444175.1 linkc.*505G>C 3_prime_UTR_variant Exon 4 of 4 XP_047300131.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL1BENST00000263341.7 linkc.*505G>C 3_prime_UTR_variant Exon 7 of 7 1 NM_000576.3 ENSP00000263341.2 P01584

Frequencies

GnomAD3 genomes
AF:
0.196
AC:
29823
AN:
151920
Hom.:
3146
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.143
Gnomad AMI
AF:
0.319
Gnomad AMR
AF:
0.174
Gnomad ASJ
AF:
0.275
Gnomad EAS
AF:
0.0221
Gnomad SAS
AF:
0.153
Gnomad FIN
AF:
0.249
Gnomad MID
AF:
0.354
Gnomad NFE
AF:
0.235
Gnomad OTH
AF:
0.211
GnomAD4 exome
AF:
0.182
AC:
715
AN:
3926
Hom.:
82
Cov.:
0
AF XY:
0.185
AC XY:
384
AN XY:
2076
show subpopulations
African (AFR)
AF:
0.0625
AC:
1
AN:
16
American (AMR)
AF:
0.120
AC:
110
AN:
918
Ashkenazi Jewish (ASJ)
AF:
0.286
AC:
4
AN:
14
East Asian (EAS)
AF:
0.00926
AC:
1
AN:
108
South Asian (SAS)
AF:
0.123
AC:
57
AN:
462
European-Finnish (FIN)
AF:
0.0833
AC:
2
AN:
24
Middle Eastern (MID)
AF:
1.00
AC:
2
AN:
2
European-Non Finnish (NFE)
AF:
0.227
AC:
511
AN:
2250
Other (OTH)
AF:
0.205
AC:
27
AN:
132
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
30
61
91
122
152
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.196
AC:
29840
AN:
152038
Hom.:
3151
Cov.:
32
AF XY:
0.195
AC XY:
14501
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.143
AC:
5944
AN:
41450
American (AMR)
AF:
0.174
AC:
2655
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.275
AC:
953
AN:
3470
East Asian (EAS)
AF:
0.0224
AC:
116
AN:
5182
South Asian (SAS)
AF:
0.153
AC:
738
AN:
4818
European-Finnish (FIN)
AF:
0.249
AC:
2625
AN:
10540
Middle Eastern (MID)
AF:
0.356
AC:
104
AN:
292
European-Non Finnish (NFE)
AF:
0.235
AC:
15969
AN:
67980
Other (OTH)
AF:
0.211
AC:
445
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1209
2418
3628
4837
6046
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
318
636
954
1272
1590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.220
Hom.:
552
Bravo
AF:
0.187

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.41
DANN
Benign
0.44
PhyloP100
-0.49
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1071676; hg19: chr2-113587433; API